IFAPP Academy Is Leading the Way in Education for Medicines Development Professionals

Learn More
ABOUT THE ACADEMY

Giving Medicines Development Professionals a Competitive Edge Through World-Class Education, and Connecting an Emerging Community of Learners

With an ever-changing industry and increasing demand for better medicines, the Academy provides biomedical professionals involved in drug development the training and operating network they need to stay ahead in their profession.

Whether you develop, launch, or maintain medicines, our global programs serve professionals from every stage of the product lifecycle. We partner with you to deepen your expertise, advance your career, and bring value to patients around the world.

Certification Programs

Elevate your career with courses led by our world-renowned faculty and endorsed by our partner organizations

Explore all certification programs

See Our Latest

Conversations With the Academy Webinar

How Regulatory Sciences and Stakeholder Collaboration Could Improve Access to Medical Innovation and Public Health ~ Perspectives for Latin America

We explored recent developments and initiatives in Latin America, forging stakeholder partnerships and alignment, which have facilitated creative opportunities to optimize the regulatory landscape, promising improved patents’ access to next-generation biopharmaceutical products.

Read More

Most of our students are employed or sponsored by

Academy Alumni
Cheryl Freeman
Medical Manager at Pfizer
Australia
Academy Sponsor
Roberto Araujo
Former Global Head of Medical Capability Development, Sanofi
USA
Academy Alumni
Li Xiaojing
Senior Medical Manager, CSPC Pharma Ltd.
China
Academy Sponsor
Pol Vandenbroucke
Chief Medical Officer, Hospital Business Unit, Pfizer
USA
Academy Alumni
Steven Zung
Medical Director, Aché Laboratories
Brazil

Connect With Peers and Industry Leaders From Around the World

When you join the Academy, you become a member of a global community of Medicines Development professionals.

Learn More

What Partners and Alumni Are Saying

“The IFAPP Academy-King’s College London course has given me a thorough understanding of the whole drug development process which should be patient-centered. The knowledge I have learned from both the world-top professors and outstanding classmates would definitely aid me to realize my dream!”

Xiaojing Li
Senior Medical Manager, CSPC Pharma Ltd.
China

“The IFAPP Academy-King’s College London course helped me paint a lucid picture of the role of medical affairs in mind. Currently working in a research institution, the learnings pertaining to drug development and clinical trials proved to be immensely beneficial to my daily job.”

Nishtha Khatri
Assistant Professor, KEM Hospital, Seth Gordhandas Sunderdas Medical College
India

“In a world increasingly globalized, with a growing trend of cooperation for the development of new medicines and harmonization of regulatory requirements, the IFAPP Academy-King’s College London course helped me better understand these challenges and have a broader perspective of acting as a medical affairs professional.”

Stevin Zung
Medical Director at Aché Laboratories
Brazil

“I have greatly benefitted from the exchange with colleagues from all over the world. IFAPP Academy-King’s College London’s program is a truly global one.”

Sandra Bosold
Senior Pharmaceutical Advisor, Pfizer
Germany

“IFAPP Academy-King’s College London’s Professional Certification Program is an educational program that enables Medical Affairs professionals to invest in consistent individual professional development. I know this program will play in my ability to succeed in my professional life.”

Anna Rodet
Global Clearance Committee Lead, UCB
France

“Amalgamating the critical role of Medical Affairs as custodians of the right medicine for the right patient at the right time, the IFAPP Academy-King’s College London course has empowered me with the confidence to strategically influence stakeholders via my newfound knowledge in medicines development.”

Cheryl Freeman
Medical Manager, Pfizer
Australia

Stay Updated on Biopharmaceutical Innovation

Load more
Load more
Load more
Load more

We use cookies to improve your browsing experience. Learn more about your privacy.